News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
38,226 Results
Type
Article (2444)
Company Profile (40)
Press Release (35742)
Multimedia
Podcasts (4)
Webinars (2)
Section
Business (14131)
Career Advice (77)
Deals (2079)
Drug Delivery (9)
Drug Development (4108)
Employer Resources (10)
FDA (432)
Job Trends (763)
News (20152)
Policy (1052)
Tag
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (145)
Allergies (6)
Alliances (3472)
ALS (4)
Alzheimer's disease (45)
Antibody-drug conjugate (ADC) (14)
Approvals (433)
Artificial intelligence (11)
Autoimmune disease (3)
Automation (1)
Bankruptcy (12)
Best Places to Work (475)
BIOSECURE Act (2)
Biosimilars (12)
Biotechnology (30)
Bladder cancer (6)
Brain cancer (5)
Breast cancer (19)
Cancer (139)
Cardiovascular disease (5)
Career advice (64)
Career pathing (1)
CAR-T (15)
Cell therapy (43)
Cervical cancer (2)
Clinical research (3182)
Collaboration (94)
Compensation (48)
COVID-19 (181)
CRISPR (7)
C-suite (27)
Cystic fibrosis (2)
Data (113)
Denatured (3)
Depression (3)
Diabetes (10)
Diagnostics (464)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (15)
Drug pricing (7)
Duchenne muscular dystrophy (12)
Earnings (4242)
Editorial (3)
Employer branding (1)
Employer resources (8)
Events (6028)
Executive appointments (96)
FDA (478)
Featured Employer (3)
Funding (77)
Gene editing (14)
Gene therapy (18)
GLP-1 (60)
Government (149)
Healthcare (704)
Huntington's disease (3)
IgA nephropathy (3)
Immunology and inflammation (16)
Indications (2)
Infectious disease (186)
Inflammatory bowel disease (11)
Inflation Reduction Act (6)
Influenza (4)
Intellectual property (10)
Interviews (7)
IPO (989)
IRA (7)
Job creations (290)
Job search strategy (62)
Kidney cancer (4)
Labor market (4)
Layoffs (37)
Leadership (1)
Legal (212)
Liver cancer (5)
Lung cancer (15)
Lymphoma (3)
Management (4)
Manufacturing (19)
MASH (4)
Medical device (307)
Medtech (307)
Mergers & acquisitions (1159)
Metabolic disorders (34)
Multiple sclerosis (7)
Neurodegenerative disease (9)
Neuropsychiatric disorders (3)
Neuroscience (91)
NextGen: Class of 2025 (353)
Non-profit (153)
Northern California (359)
Now hiring (4)
Obesity (16)
Opinion (15)
Ovarian cancer (10)
Pain (9)
Pancreatic cancer (3)
Parkinson's disease (4)
Partnered (2)
Patents (22)
Patient recruitment (4)
Peanut (1)
People (5664)
Pharmaceutical (5)
Phase I (1373)
Phase II (1596)
Phase III (849)
Pipeline (74)
Policy (12)
Postmarket research (30)
Preclinical (593)
Press Release (2)
Prostate cancer (3)
Psychedelics (2)
Radiopharmaceuticals (12)
Rare diseases (22)
Real estate (420)
Recruiting (5)
Regulatory (803)
Reports (6)
Research institute (143)
Resumes & cover letters (9)
Schizophrenia (10)
Series A (25)
Series B (5)
Service/supplier (2)
Sickle cell disease (1)
Southern California (354)
Special edition (1)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (489)
Stomach cancer (1)
Supply chain (4)
The Weekly (1)
United States (1727)
Vaccines (28)
Venture capitalists (8)
Weight loss (12)
Women's health (1)
Worklife (1)
Date
Today (4)
Last 7 days (37)
Last 30 days (209)
Last 365 days (2547)
2025 (750)
2024 (2613)
2023 (2873)
2022 (3762)
2021 (4050)
2020 (3475)
2019 (2062)
2018 (1554)
2017 (1795)
2016 (1624)
2015 (1833)
2014 (1369)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)
Location
Africa (43)
Alabama (1)
Arizona (14)
Asia (1864)
Australia (298)
California (828)
Canada (132)
China (38)
Colorado (20)
Connecticut (10)
Delaware (4)
Europe (3821)
Florida (44)
Georgia (5)
Idaho (3)
Illinois (14)
India (1)
Indiana (32)
Japan (7)
Kansas (12)
Maryland (25)
Massachusetts (302)
Michigan (8)
Minnesota (14)
Missouri (3)
Nebraska (1)
Nevada (3)
New Hampshire (2)
New Jersey (69)
New York (49)
North Carolina (90)
Northern California (359)
Ohio (25)
Oklahoma (2)
Oregon (4)
Pennsylvania (49)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (354)
Tennessee (2)
Texas (71)
Utah (2)
Virginia (6)
Washington D.C. (1)
Washington State (51)
Wisconsin (6)
38,226 Results for "annexon biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Neuroscience
Annexon Touts ‘Rapid’ and ‘Durable’ Improvements for Targeted Guillain-Barré Therapy
Jefferies analysts predict Annexon’s tanruprubart could be approved by mid-2026.
April 10, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Annexon Biosciences to Present at the TD Cowen 45th Annual Health Care Conference
February 26, 2025
·
1 min read
Press Releases
Annexon Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 8, 2025
·
1 min read
Press Releases
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - April 16, 2025
April 17, 2025
·
1 min read
Press Releases
Annexon Biosciences to Present at the 2024 Jefferies London Healthcare Conference
November 14, 2024
·
1 min read
Press Releases
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - March 17, 2025
March 18, 2025
·
1 min read
Press Releases
Annexon Highlights Leadership in Advancing Clinical Research and Education for Guillain-Barré Syndrome (GBS) at American Academy of Neurology (AAN) 2025 Annual Meeting
April 4, 2025
·
5 min read
Biotech Bay
Annexon Biosciences to Present at the Bank of America 2024 Health Care Conference
Annexon, Inc. announced that Douglas Love, president and chief executive officer, will present at the Bank of America Health Care Conference on Tuesday, May 14, 2024 at 8:40 a.m. PT.
May 9, 2024
·
1 min read
Drug Development
Annexon’s Pivotal Phase III GBS Trial Hits Goal, Tees Up Approval Filing
Annexon’s late-stage Guillain-Barré syndrome trial has hit its primary endpoint and laid the foundation for a filing for approval next year, the company said Tuesday.
June 4, 2024
·
2 min read
·
Nick Paul Taylor
Business
Annexon Biosciences to Participate in Upcoming September Investor Conferences
August 29, 2024
·
1 min read
1 of 3,823
Next
